Lincoln Krochmal

Title: Lincoln Krochmal: Innovator in Scar Treatment

Introduction

Lincoln Krochmal is a notable inventor based in Los Gatos, California. He has made significant contributions to the field of dermatology, particularly in the treatment of keloids and hypertrophic scars. His innovative approach utilizes antisense compounds to target connective tissue growth factor (CTGF), providing a new method for preventing and treating fibrotic lesions.

Latest Patents

Krochmal holds a patent for a method of treating keloids or hypertrophic scars using antisense compounds. This invention outlines a process that involves administering a modified oligonucleotide, such as a modified antisense oligonucleotide, siRNA, or oligodeoxyribonucleotide, to inhibit the expression of proteins involved in fibrosis. The patent emphasizes the use of an intradermal threading technique for dosing the antisense compounds, which enhances the effectiveness of the treatment.

Career Highlights

Throughout his career, Lincoln Krochmal has worked with various companies, including Excaliard Pharmaceuticals, Inc. His experience in the pharmaceutical industry has allowed him to develop and refine his innovative approaches to scar treatment. His work has the potential to significantly improve the quality of life for individuals suffering from fibrotic skin conditions.

Collaborations

Krochmal has collaborated with notable professionals in his field, including Nicholas M. Dean and Gregory E. Hardee. These collaborations have contributed to the advancement of his research and the development of effective treatment methods.

Conclusion

Lincoln Krochmal's contributions to the field of dermatology through his innovative patent demonstrate his commitment to improving patient outcomes. His work in treating keloids and hypertrophic scars showcases the potential of antisense technology in medical applications.